Alternatives to Alto Neuroscience

Developing novel therapeutics to restore gut lymphatic function.

Biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

AI-powered platform for antibody discovery and development to create new medicines.

Leveraging the adaptive immune system to diagnose and treat disease.

Developing engineered biologics to harness the immune system for disease treatment.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Personalized medical testing tool to optimize drug therapy for depression.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

Canadian company operating in the legal psilocybin industry, focusing on cultivation, production, and distribution of psilocybin products.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Clinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies.

A global oncology company developing and commercializing innovative cancer treatments.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

AI-powered platform to predict and prevent adverse drug reactions, reducing hospitalizations.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Biotechnology company developing novel immunotherapies for cancer.

Pharmaceutical company developing transdermal cannabinoid therapeutics for behavioral and emotional conditions.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

Gene therapy company developing treatments for rare inherited diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

Global biotechnology company pioneering innovative medicines for complex neurological, neuropsychiatric, and rare diseases.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

One Biosciences is a French biotech startup leveraging single-cell multi-omics and AI to discover novel drug targets for complex diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Develops and manufactures biologics for therapeutic applications.

Biotech company focused on developing therapies to extend human healthspan and lifespan.

Developing novel therapeutics for challenging diseases using advanced biological insights.